CIK 1475373
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 57.82% | 23 |
| Health Care Equipment & Supplies | 17.45% | 7 |
| Life Sciences Tools & Services | 11.09% | 5 |
| Insurance | 7.41% | 4 |
| Distributors | 2.74% | 1 |
| Food & Staples Retailing | 2.30% | 1 |
| Health Care Providers & Services | 1.20% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BMY | BRISTOL MYERS SQUIBB CO | Health Care | 11.86% |
| 2 | MRK | Merck & Co., Inc. | Health Care | 7.39% |
| 3 | PFE | PFIZER INC | Health Care | 7.24% |
| 4 | MDT | Medtronic plc | Health Care | 5.74% |
| 5 | INCY | INCYTE CORP | Health Care | 4.46% |
| 6 | AMGN | AMGEN INC | Health Care | 3.92% |
| 7 | BIIB | BIOGEN INC. | Health Care | 3.90% |
| 8 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Health Care | 3.33% |
| 9 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 3.20% |
| 10 | BDX | BECTON DICKINSON & CO | Health Care | 3.07% |
42/42 names classified · sector 100.0% of weight · industry 100.0% · mkt cap 98.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 100.0% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 83.2% of book weight (27/42 names) · unclassified 16.8%: IONS, SNDX, QGEN, AVTR, CNC, TNDM, ASND, CRNX, KURA, BBIO +5 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BMYBRISTOL-MYERS SQUIBB CO | 827,901 | $50M | 11.9% | ADD 11% |
| 2 | MRKMERCK & CO INC | 260,340 | $31M | 7.4% | TRIM −28% |
| 3 | PFEPFIZER INC | 1,091,385 | $31M | 7.2% | ADD 27% |
| 4 | MDTMEDTRONIC PLC | 280,682 | $24M | 5.7% | ADD 4% |
| 5 | INCYINCYTE CORP | 200,510 | $19M | 4.5% | TRIM −8% |
| 6 | AMGNAMGEN INC | 47,155 | $17M | 3.9% | TRIM −23% |
| 7 | BIIBBIOGEN INC | 90,096 | $17M | 3.9% | ADD 5% |
| 8 | ZBHZIMMER BIOMET HOLDINGS INC | 155,835 | $14M | 3.3% | ADD 18% |
| 9 | BMRNBIOMARIN PHARMACEUTICAL INC | 239,918 | $14M | 3.2% | ADD 21% |
| 10 | BDXBECTON DICKINSON & CO | 82,615 | $13M | 3.1% | TRIM −38% |
| 11 | ELVELEVANCE HEALTH INC FORMERLY | 43,962 | $13M | 3.0% | ADD 35% |
| 12 | IONSIONIS PHARMACEUTICALS INC | 169,468 | $13M | 3.0% | TRIM −8% |
| 13 | CAHCARDINAL HEALTH INC | 54,897 | $12M | 2.7% | TRIM −11% |
| 14 | UNHUNITEDHEALTH GROUP INC | 36,435 | $10M | 2.3% | NEW |
| 15 | CVSCVS HEALTH CORP | 135,337 | $10M | 2.3% | TRIM −24% |
| 16 | BRKRBRUKER CORP | 254,010 | $9M | 2.2% | HOLD |
| 17 | GEHCGE HEALTHCARE TECHNOLOGIES I | 126,418 | $9M | 2.1% | ADD 11% |
| 18 | ABTABBOTT LABS | 87,532 | $9M | 2.1% | NEW |
| 19 | GILDGILEAD SCIENCES INC | 53,247 | $7M | 1.8% | TRIM −70% |
| 20 | LNTHLANTHEUS HLDGS INC | 93,344 | $7M | 1.7% | HOLD |
| 21 | IQVIQVIA HLDGS INC | 40,230 | $7M | 1.6% | NEW |
| 22 | SNDXSYNDAX PHARMACEUTICALS INC | 286,007 | $7M | 1.6% | ADD 13% |
| 23 | BIOBIO RAD LABS INC | 23,750 | $7M | 1.6% | HOLD |
| 24 | QGENQIAGEN NV | 162,371 | $7M | 1.5% | NEW |
| 25 | AVTRAVANTOR INC | 695,403 | $5M | 1.3% | HOLD |
| 26 | CNCCENTENE CORP DEL | 162,405 | $5M | 1.3% | TRIM −37% |
| 27 | TNDMTANDEM DIABETES CARE INC | 267,091 | $5M | 1.2% | HOLD |
| 28 | PTCTPTC THERAPEUTICS INC | 75,000 | $5M | 1.2% | ADD 21% |
| 29 | LHLABCORP HOLDINGS INC | 19,019 | $5M | 1.2% | TRIM −30% |
| 30 | ASNDASCENDIS PHARMA A/S | 21,305 | $5M | 1.2% | ADD 31% |
| 31 | EWEDWARDS LIFESCIENCES CORP | 60,402 | $5M | 1.1% | TRIM −37% |
| 32 | DXCMDEXCOM | 56,122 | $4M | 0.8% | TRIM −26% |
| 33 | CRNXCRINETICS PHARMACEUTICALS IN | 94,195 | $3M | 0.8% | TRIM −18% |
| 34 | KURAKURA ONCOLOGY INC | 411,810 | $3M | 0.8% | TRIM −10% |
| 35 | HUMHUMANA INC | 19,202 | $3M | 0.8% | NEW |
| 36 | BBIOBRIDGEBIO PHARMA INC | 44,263 | $3M | 0.8% | NEW |
| 37 | IOVAIOVANCE BIOTHERAPEUTICS INC | 900,000 | $3M | 0.7% | NEW |
| 38 | DNLIDENALI THERAPEUTICS INC | 162,710 | $3M | 0.7% | NEW |
| 39 | ARDXARDELYX INC | 516,131 | $3M | 0.7% | NEW |
| 40 | COGTCOGENT BIOSCIENCES INC | 80,000 | $3M | 0.7% | NEW |
| 41 | OGNORGANON & CO | 375,974 | $2M | 0.5% | ADD 25% |
| 42 | ARWRARROWHEAD PHARMACEUTICALS IN | 30,000 | $2M | 0.4% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| BMYBRISTOL-MYERS SQUIBB CO | 366K | 435K | 406K | 581K | 746K | 828K | $50M |
| MRKMERCK & CO INC | — | — | 202K | 323K | 364K | 260K | $31M |
| PFEPFIZER INC | 1.2M | 925K | 920K | 1.3M | 860K | 1.1M | $31M |
| MDTMEDTRONIC PLC | 320K | 205K | 224K | 303K | 270K | 281K | $24M |
| INCYINCYTE CORP | 197K | 159K | 204K | 205K | 219K | 201K | $19M |
| AMGNAMGEN INC | 46K | 59K | 44K | 61K | 61K | 47K | $17M |
| BIIBBIOGEN INC | 29K | 19K | 51K | 75K | 85K | 90K | $17M |
| ZBHZIMMER BIOMET HOLDINGS INC | 138K | 114K | 89K | 113K | 132K | 156K | $14M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 217K | 137K | 122K | 176K | 199K | 240K | $14M |
| BDXBECTON DICKINSON & CO | 76K | 82K | 98K | 109K | 132K | 83K | $13M |
| ELVELEVANCE HEALTH INC FORMERLY | 17K | 29K | 19K | 10K | 33K | 44K | $13M |
| IONSIONIS PHARMACEUTICALS INC | 236K | 286K | 286K | 271K | 185K | 169K | $13M |
| CAHCARDINAL HEALTH INC | 88K | 88K | 66K | 60K | 62K | 55K | $12M |
| UNHUNITEDHEALTH GROUP INC | — | — | — | — | — | 36K | $10M |
| CVSCVS HEALTH CORP | 217K | 202K | 163K | 156K | 178K | 135K | $10M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
